Sleep tool
STOP-BANG-adjacent symptoms + BMI + age. Calibrates whether to push for a sleep study and whether SURMOUNT-OSA / Zepbound therapy is in scope.
Risk band
moderate risk
Composite score: 4 / 9
Moderate risk. Worth raising with your clinician at your next visit; a home sleep test is inexpensive and often covered.
May qualify for Zepbound (OSA)
As of December 2024, Zepbound is FDA-approved for moderate-to-severe OSA in adults with obesity (BMI ≥30). Your inputs fit the risk profile; a sleep study confirms AHI severity.
Read about Zepbound for OSANot a diagnosis. Only a polysomnogram or HSAT can measure AHI directly.